- Home
- MOLN vs HNVR Comparison
MOLN vs HNVR Comparison
Compare MOLN & HNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- HNVR
- Stock Information
- Founded
- MOLN 2004
- HNVR 2008
- Country
- MOLN Switzerland
- HNVR United States
- Employees
- MOLN N/A
- HNVR N/A
- Industry
- MOLN
- HNVR Commercial Banks
- Sector
- MOLN
- HNVR Finance
- Exchange
- MOLN Nasdaq
- HNVR Nasdaq
- Market Cap
- MOLN 183.2M
- HNVR 163.2M
- IPO Year
- MOLN 2021
- HNVR 2022
- Fundamental
- Price
- MOLN $3.88
- HNVR $22.32
- Analyst Decision
- MOLN
- HNVR Buy
- Analyst Count
- MOLN 0
- HNVR 1
- Target Price
- MOLN N/A
- HNVR $22.00
- AVG Volume (30 Days)
- MOLN 4.4K
- HNVR 10.4K
- Earning Date
- MOLN 03-06-2025
- HNVR 04-16-2025
- Dividend Yield
- MOLN N/A
- HNVR 1.81%
- EPS Growth
- MOLN N/A
- HNVR N/A
- EPS
- MOLN N/A
- HNVR 1.66
- Revenue
- MOLN $5,484,562.00
- HNVR $63,491,000.00
- Revenue This Year
- MOLN N/A
- HNVR N/A
- Revenue Next Year
- MOLN $528.57
- HNVR $16.61
- P/E Ratio
- MOLN N/A
- HNVR $13.64
- Revenue Growth
- MOLN N/A
- HNVR 5.04
- 52 Week Low
- MOLN $3.32
- HNVR $13.62
- 52 Week High
- MOLN $12.70
- HNVR $27.14
- Technical
- Relative Strength Index (RSI)
- MOLN 39.32
- HNVR 42.19
- Support Level
- MOLN $3.76
- HNVR $22.29
- Resistance Level
- MOLN $4.56
- HNVR $23.00
- Average True Range (ATR)
- MOLN 0.29
- HNVR 0.97
- MACD
- MOLN 0.02
- HNVR 0.10
- Stochastic Oscillator
- MOLN 11.87
- HNVR 48.00
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About HNVR Hanover Bancorp Inc.
Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.